24. [IF=1.8] Xiaofeng Li et al."Pharmacokinetic study of multicomponent in Hong-Hua-Xiao-Yao tablet."BIOMEDICAL CHROMATOGRAPHY".2024 Mar;:e5830 23. [IF=1.8] Qin Fan et al."Integration of metabolomics and network pharmacology technology to explain the effect mechanisms of Danggui Buxue decoction in vascular dementia."BIOMEDICAL CHROMATOGRAPHY.2024 Jan;:e5822 22. [IF=3.4] Jiaxin Yin et al."Comprehensive multicomponent characterization and quality assessment of Xiaoyao Wan by UPLC-Q-Orbitrap-MS, HS-SPME-GC-MS and HS-GC-IMS."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS.2024 Feb;239:115910 21. [IF=5.988] Sa Li et al."Suxiao Jiuxin Pill attenuates acute myocardial ischemia via regulation of coronary artery tone."Frontiers in Pharmacology.2023; 14: 1104243 20. [IF=4.36] Jing Chen et al."Salvianolic acid B and ferulic acid synergistically promote angiogenesis in HUVECs and zebrafish via regulating VEGF signaling."J Ethnopharmacol. 2021 Sep;:114667 19. [IF=5.34] Tao-Fang Cheng et al."Compound Dan Zhi tablet attenuates experimental ischemic stroke via inhibiting platelet activation and thrombus formation."Phytomedicine. 2020 Dec;79:153330 18. [IF=5.81] Jun Li et al."Synergistic Effects of Cryptotanshinone and Senkyunolide I in Guanxinning Tablet Against Endogenous Thrombus Formation in Zebrafish."Front Pharmacol. 2020; 11: 622787 17. [IF=3] Han CHEN et al."Chemical profile of the active fraction of Yi-Gan San by HPLC-DAD-Q-TOF-MS and its neuroprotective effect against glutamate-induced cytotoxicity."Chin J Nat Medicines. 2014 Nov;12:869 16. [IF=3.922] Nating Zhang et al."Pharmacokinetics-Based Identification of Potential Therapeutic Phthalides from XueBiJing, a Chinese Herbal Injection Used in Sepsis Management."Drug Metab Dispos. 2018 Jun;46(6):823-834 15. [IF=4.379] Chen Wei-Ren et al."Phthalide Derivatives from Angelica Sinensis Decrease Hemoglobin Oxygen Affinity: A New Allosteric-Modulating Mechanism and Potential Use as 2,3-BPG Functional Substitutes."Sci Rep-Uk. 2017 Jul;7(1):1-15 14. Han, C. H. E. N., et al. "Chemical profile of the active fraction of Yi-Gan San by HPLC-DAD-Q-TOF-MS and its neuroprotective effect against glutamate-induced cytotoxicity." Chinese journal of natural medicines 12.11 (2014): 869-880.https://doi.org/10.1016/ 13. Li J, Liu H, Yang Z, Yu Q, Zhao L, Wang Y. Synergistic Effects of Cryptotanshinone and Senkyunolide I in Guanxinning Tablet Against Endogenous Thrombus Formation in Zebrafish. Front Pharmacol. 2021;11:622787. Published 2021 Jan 14. doi:10.3389/fphar.2020.6 12. Zulfajri, Muhammad. "Influences of allosteric effectors on the structure and functionality of human hemoglobin." (2014). 11. 彭桐,王引權,張亞麗,荔淑楠,雒軍,馬琴國.臨洮當歸與岷縣當歸8種有效成分比較[J].甘肅中醫藥大學學報,2020,37(06):29-33. 10. 胡楊,丁曉倩,嚴輝,吳垠志,彭國平,黃勝良.川芎質量標準的研究[J].中成藥,2021,43(03):692-699. 9. 鄧雪琪,管小軍,黃娜娜,李俊.HPLC法同時測定當歸中8種成分[J].中成藥,2020,42(08):2075-2079. 8. 毛文點,庹玲玲,齊文續,蘇睿智,鄧常清,鄒龍.黃芪-當歸不同配伍對其6種主要有效成分溶出的影響[J].湖南中醫藥大學學報,2021,41(03):350-354. 7. 鄧雪琪 管小軍 黃娜娜 李俊.HPLC法同時測定當歸中8種成分[J].中成藥 2020 42(08):2075-2079. 6. 王振恒, 王引權, 樊秦,等. 紫外線-B輻射對當歸苯酞類成分含量的影響[J]. 甘肅中醫藥大學學報, 2019(6). 5. 趙蓉, 蔣俊, 肖世長, et al. 桃紅四物湯逆轉斑馬魚模型糖皮質激素性骨質疏松的研究[J]. 藥學學報, 2019, 54(02):143-150. 4. 石海培,包貝華,黃勝良,汪國強,左武朋,嚴輝,張麗.當歸飲片指紋圖譜及模式識別研究[J].時珍國醫國藥,2019,30(02):364-368. 3. 陳冉, 尹丹丹, 楊沫,等. 超高效液相色譜法比較鮮川芎和川芎藥材中6種成分含量[J]. 安徽中醫學院學報, 2019, 038(006):84-88. 2. 郭麗, 吳莎, 王晶,等. 芎附滴丸的制備工藝及主要成分的含量測定研究[J]. 中華中醫藥雜志, 2019, v.34(12):402-405. 1. 婁燕 賈英 何博賽 等. RP-HPLC雙波長法同時測定酸棗仁湯中5種成分的含量[J]. 沈陽藥科大學學報 2013(07):47-52.